Melanoma & Skin Cancers
Quick Links
Commentary
News
Video
NewsMore ›

T-VEC improved durable response rate in advanced melanoma
Treatment with the oncolytic immunotherapy talimogene laherparepvec (T-VEC) resulted in significantly longer rates of durable response and overall response, compared with... More »

Nicotinamide cuts rate of nonmelanoma skin cancer in those at high risk
Nicotinamide, an inexpensive, over-the-counter form of vitamin B3, is safe and efficacious for the chemoprevention of nonmelanoma skin cancer in patients at high risk,... More »

Dr. Mark Middleton

AACR: IMCgp100 activity eyed in ocular melanoma
The first-in-class immunotherapy IMCgp100 was active in late-stage melanoma, particularly ocular melanoma, in an ongoing, phase I/IIa trial. Four of 14 patients treated with... More »

CommentaryMore ›

Point/Counterpoint: What is the first-line treatment of choice for metastatic BRAF-mutant melanoma?
Dr. Mario Sznol and Dr. Jeffrey Sosman debate immunotherapy vs. BRAF-targeted therapy.

Mini X-Ray Device Treats Nonmelanoma Skin Cancers
MIAMI BEACH – An x-ray tube about the size of a sewing needle can safely deliver radiation to nonmelanoma skin tumors on the nose, scalp, or other highly visible areas of... More »

  VideoMore ›

VIDEO: Updating the immune response to nonmelanoma skin cancer
ASHEVILLE, N.C. – Recent advances in basic science have shown how the local immune environment in tissue surrounding nonmelanoma skin cancer compares to adjacent normal... More »

VIDEO: Larger lentigo maligna lesions increase risk
ASHEVILLE, N.C. – What are the risk factors for invasive melanoma in patients with lentigo maligna? Size, for one thing, according to Dr. Suzanne M. Olbricht. In an... More »

VIDEO: Sun protection urged for Asian, Hispanic women
SAN FRANCISCO – Among Asian and Hispanic patients, women are more likely than men are to get nonmelanoma skin cancer, according to a review of 4,029 cases at the University... More »